Position
ALLIANCEBERNSTEIN L.P. in Arbutus Biopharma Corp
Back to the book · All holders of ABUS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1$4.81 → $4.81
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 143.9K | $692K | — | — | — | 0.0% |
| Q1 2026 | 127.3K | $612.5K | $4.81 | −$1 | −$79.5K | 0.0% |